Drugs / QH10304-BAL-01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06696833 | Dec 2024 → Dec 2025 overdue | B-cell acute lymphoblastic leukemia | The First Affiliated Hospital of Soochow University | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | QH10304-BAL-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06696833 ↗ |
| Modality | Cell therapy | “allogeneic CD19-targeted CAR-γδT Cell” NCT06696833 ↗ |
| Route | Intravenous | “i.v. injection” NCT06696833 ↗ |
| Target | CD19 | “CD19-targeted CAR-γδT Cell” NCT06696833 ↗ |